Member Info for smalltrader

how about ITV raise funds via share placing and buy a major in media sector like Entertainment One? or even Channel 4 or another other TV company in Europe for cheap? Go on acquisition spree in Europe? Just a thought.......

why I think this is looking good -

1) MTFB attended health conference even after receiving CRL. Someone like Scott would not go to such conference if he thinks CRL and the content in it is the final nail in the coffin. Clearly MTFB are confident of their product and not worried about CRL so they attended conference with confidence to answer any questions about CRL if any from anyone.

2) They appointed a new director who is the best in the MTFB team for marketing and commercializing Iclaprim. They wouldn't appoint a director now when they think the finances are not good and if they think there is no path way forward for Iclaprim! Clearly, they seem to see the way forward for Iclaprim!

3) The placing at 6p was successful and this wouldn't be successful if investors were not confident on the product.

4) In the webcast, they mentioned that there is no need for trials so it is clearly a minor issue which they are confident that they can deal with.

5) Major IIs are still holding and have not closed their cards yet including AMP betting on for approval!

6) They wouldn't request for FDA meeting after receiving CRL if they think that FDA would reject it like the first time when it was rejected.

7) In the final results RNS, they were even talking about submission to EMA! They wouldn't even think that far if they were not confident of approval?

8) If Vancomycin is already there in the market then FDA wouldn't have worked with MTFB after they initially rejected back in 2009? Clearly there is a billion market for Iclaprim so once it is approved, the partners waiting on the wings would pour in offers for MTFB.

Feel free to add more that I may have missed!

So it definitely is looking very good for me!

E121, considering Kraken output to be at 30K avg for this year although the average could be lot higher than 30K, how much could be the debt reduction by Dec 2019 assuming POO averaging $65 until Dec 2019? Sorry please don't think am tasking you this morning. I'm not sure how to calculate it so would like to learn the calculations and will remember it. I'm a IT Admin guy so zero knowledge at accountancy! :-)

https://www.ft.com/content/f4872aea-757c-11e9-bbad-7c18c0ea0201

This is still a FTSE 100 share but don't know if it will be booted out of FTSE100! 4% drop for a FTSE 100 might be a big thing but really it is not a big drop. Dividends are still in place although they are not massive. Once dust settles it will be back to 125 easily. US and China deal can bring some momentum here too. I'm thinking to buy on Monday. Where is hi-hi?

can someone explain what the holdings RNS from Morgan Stanley mean? Are they selling or are they accumulating? I see similar RNS from Morgan for another share and that is very volatile and thinking it could be due to JP Morgan manipulating the SP?

Could be due to wider market concerns and nothing related to MTFB specific as nothing changed since yday when it was 9.3p

Bloody trump and it's trade war is effecting every sector.

W.r.t MTFB from Monday next week, we need to keep our eyes wide open as RNS can land anytime.

nothing is a straight line so what goes down will come back up again! patience needed...thinking of topping up tomorrow for trading...sold few chuncks at 20.87 last week

Yes goes ballistic and auction if approved. Wondering if ADRs in US market would have larger gains than in AIM here? Thinking of buying in US market but not sure of things like CGT.
Also AMP shares would go ballistic so a small purchase in AMP might be a good idea?

Best wishes to Ian and Chartman.

Each day we are getting closer to the decision. Meeting minutes could arrive as early as next week too if Friday's meeting goes well. May not be by Friday next week but the week after that it can land anytime!

Today's RNS didn't sound like a big bang tonight market. Seeing the title of the RNS , I thought it was about partnership for commercialisation! Would be helpful if someone can throw some light on the significance of the RNS at this stage?

KO, here is the nice positive article on ENQ that you asked - https://seekingalpha.com/article/4257779-enquest-deleveraging-essential

this week Friday! finally we are getting close to the FDA decision.

I still believe this will come good as FDA did not outright rejected it. They are aware of the trial design for phase 3 and MTFB did a rolling submission for NDA so FDA has all the data they need and just need to know the strategy about addressing liver impact in a face to face meeting. Hopefully independent liver experts would be able to alleviate all the concerns from FDA.

MTFB is confident as well and appointed a new director just a week before FDA meeting. Hopefully there should not be any further surprises from FDA! Meeting minutes could arrive before AGM?

This is the opportunity for MTFB as well to ask FDA on how they are allowing Vancomycin to be prescribed when it has adverse effects on kidneys with patients dying!

Thanks Italian.

I do not think that is a placing of 170mln shares at 1p. If it is going to be at 1p then why did they raise the last one at 6p? If it is going to be at 1p then they would also be mentioning about the reasons for the discount on the prevailing market price at that time. To me it just only means that they are called penny shares as it is listed on AIM. So for a FTSE 100 share like Taylor wimpey, they call it 10p shares but that doesn't mean placing is done at 10p.

Looks like we all have to wear trading gloves to get our moNey back. Losing patience waiting for my 25p avg but again can we time the market for short term trading? Not me :-( but will top up on Monday just for trading and will see how it goes. Looks like 21p is resistance as long as POO is close to 72.

Q1 update coming and before that if poo is back to 74 then 25p this time may be? Hope so.....Good weekend all

To me this is now more than 50% chance for approval and am sure all those invested feel the same. It was a coin toss situation on Feb 13 but not any more.

On May 3rd, the discussion with FDA could give some hint about which way FDA are going but until meeting minutes are arrived it will be pure speculation even for MTFB and for IIs who will ask MTFB about how well the discussion was. It will be like a job interview you may think that you may have done well or not done well but until you hear from the employer you will not know the end result.

As the CRL mentioned only about liver toxicity issues so it is just matter of providing all the info that FDA needs. As MTFB mentioned in the call that they do Not see any need for new trials and MTFB participating in conferences still and successful placing shows huge vote of confidence!

As they were able to attend even conference in the time they have shows that MTFB is quite well prepared and relaxed about May 3rd meeting so why should we panic. Just ignore the noise from trolls.

FDA is just being cautious to get all the info they need before they approve this blockbuster drug as once approved it will be all over the news as everyone is waiting for a new antibiotic and Iclaprim is the one!

Anyone saying this will not be a multi bag even after approval should jump into a kitchen sink hole and then get treated by Iclaprim to see how effective it is!

as mentioned by Ian in the previous post - "the CRL did not ask for any further trials (stated in conference call) "

Big buy just went through as well! should see 12p next week and further higher after May 3rd! GLA

MTFB clearly mentioned that CRL is about liver toxic issues so why you think they are hiding something else that is more serious? Why do you need every word in the letter from FDA?
The gist of CRL is liver toxicity and MTFB seem to be confident of addressing it.

Hope this is the last time ppl would stop asking about
- full disclosure of CRL
- director purchase

Welcome if there are any new questions! :-)

I think these builds will give a proper justification to OPEC to not cut the supply thus POO would stay above 70+ or 75 even!

Seems to be the new avatar of Petch.

Petch said talked all gloom and doom when SP was 25p in Nov Dec time and said no news for SP to rise from 25p until Feb 13th but to his surprise although Not to me, SP gone up from 25p to 45p with usual news about conferences!

He is just a scarecrow. After fiscal year RNS that Scott mentioned, SP went up to 9.5p from 6p when everyone read about fund raising mentioned in RNS. This has further upside and we are in a much better position than pre-Feb 13th.

Before FDA meeting, we could see this rising above 10p.

Fund raising may not be even needed if MTFB is confident about the outcome of the FDA meeting as the partners waiting in line may throw an offer to MTFB. Once we see agenda for AGM we will know more details.